EVALUATION OF HYPOLIPIDEMIC EFFECT OF OF GREEN COFFEE BEAN EXTRACT (COFFEA CANEPHORA PIERRE EX A. FROEHNER) GROWN IN DAK LAK PROVINCE

Hà Hoàng Anh Vĩnh; Nguyễn Tố Uyên; Hoàng Thị Minh Thu; Trần Mạnh Hùng; Lê Trung Khoảng

doi:10.34238/tnu-jst.7925

EVALUATION OF HYPOLIPIDEMIC EFFECT OF OF GREEN COFFEE BEAN EXTRACT (COFFEA CANEPHORA PIERRE EX A. FROEHNER) GROWN IN DAK LAK PROVINCE

About this article

Received: 15/05/23 Revised: 13/06/23 Published: 13/06/23

Authors

1. Ha Hoang Anh Vinh, Buon Ma Thuot Medical University
2. Nguyen To Uyen, Buon Ma Thuot Medical University
3. Hoang Thi Minh Thu, Buon Ma Thuot Medical University
4. Tran Manh Hung, University of Medicine and Pharmacy at HCMC
5. Le Trung Khoang , Buon Ma Thuot Medical University

Abstract

The aim of the study is to evaluate the oral acute toxicity and hypolipidemic effect of green coffee bean extract (GCBE) on Swiss albino mice. The GCBE was standardized before testing. The model of hyperlipidemia in mice was induced by tyloxapol (Triton WR 1339), and the extract was evaluated at doses of 100 mg/kg and 200 mg/kg of body weight. The hypolipidemic effect was evaluated by the level of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and total cholesterol (TC) in serum. For oral acute toxicity, the LD₅₀ of GCBE on mice was 5.24 ± 0.75 g/kg. The results of lipid indices showed that the GCBE at doses of 150 mg/kg and 300 mg/kg reduced LDL-C, TG, and TC compared to the pathological group (p < 0.05). The hypolipidemic effect of GCBE 300 mg/kg was comparable to that of atorvastatin 64 mg/kg. The experimental results of this study suggest that GCBE could be used as an adjunct therapy for the treatment of dyslipidemia.

Keywords

Acid chlorogenic; Green coffee bean; Caffeine; Acute toxicity; Hypolipidemia

Full Text:

PDF (Tiếng Việt)

References

[1] V. Hoang and A. Nguyen, "PGI Buon Ma Thuot Coffee in Vietnam," in Sustainability of European Food Quality Schemes: Multi-Performance, Structure, and Governance of PDO, PGI, and Organic Agri-Food Systems, F. Arfini and V. Bellassen (Eds). Cham: Springer International Publishing, 2019, pp. 265-285.

[2] A. Farah, T. de Paulis, L. C. Trugo, and P. R. Martin, "Effect of Roasting on the Formation of Chlorogenic Acid Lactones in Coffee," Journal of Agricultural and Food Chemistry, vol. 53, no. 5, pp. 1505-1513, 2005.

[3] M. Jeszka-Skowron, A. Sentkowska, K. Pyrzyńska, and M. P. De Peña, "Chlorogenic acids, caffeine content and antioxidant properties of green coffee extracts: influence of green coffee bean preparation," European Food Research and Technology, vol. 242, no. 8, pp. 1403-1409, 2016.

[4] M. Naveed et al., "Chlorogenic acid (CGA): A pharmacological review and call for further research," Biomedicine & Pharmacotherapy, vol. 97, pp. 67-74, 2018.

[5] H. Roshan, O. Nikpayam, M. Sedaghat, and G. Sohrab, "Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial," British Journal of Nutrition, vol. 119, no. 3, pp. 250-258, 2018.

[6] V. P. Nguyen, "Applying new technology to produce functional foods from green coffee beans," (in Vietnamese), Vietnam Journal of Science, Technology and Engineering, no. 4A, pp. 31-33, 2022.

[7] T. T. H Do, "Study on technology to extract chlorogenic acid (CGAs) from green coffee beans meeting export standards as materials for health protection products to prevention and treatment of metabolic syndromes," Presented at the Independent project of Vietnam Academy of Science and Technology, Institute of Natural Products Chemistry, 2021.

[8] Ministry of Health, Vietnamese Pharmacopoeia V, Medical Publishing House, Appendix 203 - 204 - 205, 2017.

[9] H. A. V. Ha, T. T. H. Hoang, V. C. Huynh, L. P. Tran, and T. K. Le, "Validation of a simultaneous quantification method of caffeine and chlorogenic acid contents in green coffee bean by using high performance liquid chromatography," (in Vietnamese), TNU Journal of Science and Technology, vol. 228, no. 5, pp. 308-315, 2023.

[10] Ministry of Health, Decision No. 141/QD-K2DT: Decision on promulgating the “Guidance for preclinical and clinical trials of traditional medicine and herbal drugs” dated October 27, 2015," 2015.

[11] T. D. Do, Methods for determining drug toxicity, Medical Publishing House, 2014.

[12] N. T. Huynh, B. Y. Nguyen, T. T. T. Vu, T. T. Tran, and P. M. Mai, "Pharmacological effect of different fractional extracts from plants of okra Abelmoschus esculentus L. Malvaceae in mice," (in Vietnamese), Ho Chi Minh City Journal of Medicine, vol. 17, supplement of no. 4, pp. 429-433, 2013.

[13] E. Zeiger, "Chlorogenic Acid [327-97-9] and Caffeic Acid [331-39-5]. Review of Toxicological Literature," National Institute of Environmental Health Sciences, 1998, pp. 1-120.

[14] R. H. Adamson, "The acute lethal dose 50 (LD50) of caffeine in albino rats," Regulatory Toxicology and Pharmacology, vol. 80, pp. 274-276, 2016.

[15] M. Noirot, P. Barre, C. Duperray, J. Louarn, and S. Hamon, "Effects of caffeine and chlorogenic acid on propidium iodide accessibility to DNA: consequences on genome size evaluation in coffee tree," Annals of botany, vol. 92, pp. 259-264, 2003.

[16] W. C. S. Faria et al., "Acute and subacute oral toxicity assessment of dry encapsulated and non-encapsulated green coffee fruit extracts," J Food Drug Anal, vol. 28, no. 2, pp. 337-355, 2020.

[17] V. Q. Le, V. M. Can, V. N. Nguyen, and T. N. Nguyen, "Acute toxicity of the vietnem green coffee bean extract in experimental animals," (in Vietnamese), Vietnam Medical Journal, vol. 509, no. 2, pp. 30-33, 2021.

[18] P. Nawrot, S. Jordan, J. Eastwood, J. Rotstein, A. Hugenholtz, and M. Feeley, "Effects of caffeine on human health," Food Addit Contam, vol. 20, no. 1, pp. 1-30, 2003.

[19] A. Salazar-Gómez, A. C. Sánchez-Chávez, G. Zepeda-Vallejo, G. Chamorro-Cevallos, L. Garduño-Siciliano, and E. Vargas-Díaz, "Hypolipidemic Effect of Trixis angustifolia Aqueous Extract on Triton WR-1339- and High-Fat Diet-Induced Hyperlipidemic Mice," Natural Product Communications, vol. 14, no. 7, pp. 1-6, 2019.

[20] M. S. Zarzecki, S. M. Araujo, V. C. Bortolotto, M. T. de Paula, C. R. Jesse, and M. Prigol, "Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice," Toxicol Rep, vol. 1, pp. 200-208, 2014.

[21] D. F. Carrageta, T. R. Dias, M. G. Alves, P. F. Oliveira, M. P. Monteiro, and B. M. Silva, "Anti-obesity potential of natural methylxanthines," Journal of Functional Foods, vol. 43, pp. 84-94, 2018.

[22] A. Kogure et al., "Effects of caffeine on the uncoupling protein family in obese yellow KK mice," Clin Exp Pharmacol Physiol, vol. 29, no. 5-6, pp. 391-394, 2002.

[23] L. Wu et al., "Caffeine inhibits hypothalamic A1R to excite oxytocin neuron and ameliorate dietary obesity in mice," Nature Communications, vol. 8, no. 1, 2017, Art. no. 15904.

[24] L. T. Zhang, C. Q. Chang, Y. Liu, and Z. M. Chen, "Effect of chlorogenic acid on disordered glucose and lipid metabolism in db/db mice and its mechanism," Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 33, no. 3, pp. 281-286, 2011.

107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;

mso-fareast-theme-font:minor-latin;color:red;mso-ansi-language:EN-US;

mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>

field-end'>

DOI: https://doi.org/10.34238/tnu-jst.7925

Refbacks

There are currently no refbacks.



Remember me